Happy 81st Vietnam National Day

Post-laser recovery technology: what the evidence actually supports

Cooling, ultrasound-assisted delivery, oxygen, LED — how strong is the evidence for each after a laser session? And why what goes onto the skin matters more than the device pushing it in.

Eternal Team21 tháng 8, 202622 min read

No recovery technology is required for skin to heal after a laser session. Skin heals on its own, and the three things that decide the outcome are still barrier-repair moisturising, strict sun protection, and not picking the crusts. Support devices — cooling, ultrasound or iontophoretic delivery, oxygen, LED light — mostly make that period more comfortable. The strongest evidence today does not sit with the device pushing something into the skin; it sits with what is being applied.

This article works through each group at its real level of evidence, including where the honest answer is "not enough data yet". If someone is offering you a high-tech recovery package after your laser session, this is the basis for asking the right questions.

1. Skin after laser is in a very different state — and that reverses several habits

Ablative fractional laser works by creating thousands of microscopic columns of injury through the stratum corneum down into the dermis, with intact skin left in between. The mechanism is covered in detail in fractional CO2 laser. What matters here is the consequence: for the first hours, the skin barrier is not closed.

That is why freshly lasered skin cannot be treated like normal skin — and equally cannot be treated like a barrier damaged by overusing actives. The two sound similar and are fundamentally different. One is a barrier that has been gradually worn down and needs time to rebuild; the other is an acute, controlled, clean, shallow wound that will close through the normal healing sequence.

This open state has three practical consequences:

  • Everything applied penetrates further than it normally would. This is the founding principle of laser-assisted drug delivery, a well-studied technique in dermatology that uses the laser-created channels to carry a chosen medication deeper.

  • Which means mistakes also penetrate further. The same serum that only stings on intact skin can cause prolonged contact dermatitis on lasered skin. Periprocedural care guidance specifically warns against topical antibiotics containing neomycin because of high rates of allergic contact dermatitis.

  • The laser itself is already the most powerful delivery device in the room. This is the pivot of the whole article, and section 3 returns to it.

Put differently: the right question after a laser session is not "is there a technology that pushes actives deeper", but "does what is going in deserve to go that deep".

2. The four groups of technology you will encounter

Post-procedure support systems usually bundle several modes into one platform. The table summarises; the sections that follow take each in turn.

Group

Principle

Evidence for the post-laser setting

Cooling (contact tips, chilled air, pulsed cryogen)

Lowers surface temperature, slows pain conduction, constricts vessels

Clear for pain reduction and epidermal protection during treatment; after the session it is mainly soothing. There is a warning signal in darker skin

Delivery by ultrasound / iontophoresis / pressure

Increases penetration through the stratum corneum

Data come mostly from intact skin; no good evidence for freshly ablated skin

Pressurised oxygen, hydrating mist

Surface hydration, soothing sensation

Weak — small studies, often uncontrolled, frequently manufacturer-funded

LED light (red, near-infrared)

Modulates inflammation, supports healing

The most studied of the four, yet results are inconsistent; any effect is modest and short-lived

One caveat before going further: nearly every study in this field is small. An Australian expert panel reviewing skincare around energy-based device procedures concluded plainly that the evidence for most actives and regimens at this stage is sparse and drawn mainly from small-sample studies — and that review was itself sponsored by a cosmetics company. Any number in this field deserves the follow-up question: who funded the study?

3. Cooling — the clearest physiological rationale, but not harmless

A gel pack applied through clean fabric — how to soothe freshly treated skin without putting cold directly on it

Cooling is the easiest mode to understand. Lowering surface temperature slows conduction along pain fibres, constricts local vessels so immediate swelling and erythema are reduced, and draws off residual heat left in the epidermis.

In practice, cooling is classified by timing: before the pass (protects the epidermis and permits higher fluence), during the pass (parallel cooling, pain control), and after the pass (soothing). These are three different purposes — a provider saying "the machine has cooling" tells you nothing about which stage they use it at.

For pain, the evidence is convincing. A prospective study of patients treated with fractional CO2 laser recorded clearly lower self-reported pain scores with chilled air than without, and the authors also noted fewer thermal side effects. That is the most legitimate reason for a provider to invest in a cooling mode.

The part rarely mentioned: cooling may not be neutral in pigment-prone skin

This is where caution matters, particularly for Vietnamese skin.

A randomised, controlled, split-face study in 23 Thai women with Hori's nevus, published in Archives of Dermatology in 2007 (Manuskiatti et al.), compared a cold-air-cooled facial side with an uncooled side during treatment with a 1064-nm Q-switched Nd:YAG laser. The result: post-inflammatory hyperpigmentation occurred in 62% (13/21) of cooled sides versus 24% (5/21) of uncooled sides — relative risk 2.6 (95% CI 1.13–6.00; p = 0.03). The authors stated the mechanism remains unknown and called for further study of other cooling methods.

The finding needs reading carefully, because it is easy to misuse in both directions:

  • The study was not about fractional CO2 laser. It used a different laser, for a different pigmented lesion, with cooling applied during the pass — not a cold compress afterwards.

  • It does not license the conclusion "don't cool after laser". Cooling after a procedure to reduce swelling and soothe the skin remains common and reasonable advice.

  • What it does show is important: cooling is not automatically harmless, and in darker skin the assumption that "cold reduces inflammation, therefore cold reduces pigmentation" is not supported by data.

Review literature on cooling devices lists adverse effects of cooling itself: frostbite with excessive chilling, and arcuate hyperpigmentation reported with pulsed cryogen spray.

For a patient, the practical conclusion is shorter: cooling should be a clinical decision, not an add-on sold by the session. If you are prone to post-inflammatory hyperpigmentation, say so before treatment begins — that risk group is described in does CO2 laser cause hyperpigmentation in Vietnamese skin.

4. Ultrasound, iontophoresis and pressure delivery — elegant theory, misplaced data

Low-frequency ultrasound produces cavitation that temporarily disrupts the lipid structure of the stratum corneum, allowing more of an active to pass through. The mechanism is real and has been studied since the middle of the last century, and pharmaceutical studies record substantial penetration gains for certain molecules.

The problem lies elsewhere: almost all of that data was generated on intact skin or laboratory skin models. An intact stratum corneum is precisely the barrier sonophoresis is designed to get past. On skin where a laser has just created thousands of microchannels, that barrier has already been removed — far more thoroughly. Whether "pushing" adds anything in that context has not been demonstrated.

Laser-assisted drug delivery does have genuine evidence, but the distinction must be kept sharp: it is a medical procedure, using a specific drug chosen by a physician for a specific indication — intralesional corticosteroid for hypertrophic scars, methotrexate for localised scleroderma, and others. A safety review presented at the American Academy of Dermatology, pooling 71 studies, reported a generally favourable safety profile, with transient erythema, burning, oedema and superficial crusting as the common adverse events. That is not a basis for pushing a commercial serum into the same channels.

How to read the "delivery" mode, then

It is not dangerous when the solution used is appropriate and sterile. It can also be pleasant — cool, gentle, attentive. But if it is presented as a decisive factor in your treatment outcome, that is an overstatement.

And the more important question remains the one from section 1: what is in the solution? For the first 48–72 hours, post-laser guidance consistently avoids retinoids, AHA/BHA, fragrance and alcohol. Which actives wait, and why, is set out in skincare actives.

5. Oxygen and misting — the thinnest evidence of the four

This is the most pleasant group to experience and the weakest under scrutiny.

Two recent studies illustrate the problem. A randomised pilot trial of a carboxytherapy mask after fractional ablative CO2 laser enrolled 10 participants, of whom the control group was two people, all Fitzpatrick skin types I–III, funded by the manufacturer; the authors themselves acknowledged the findings were not representative of the wider population. A retrospective case series of a hypochlorous acid mist after laser likewise had 10 patients, no control group, and a lead author who founded the company producing the product.

None of this makes these methods useless. It means nobody has yet shown they change the treatment outcome — and the price of an "oxygen recovery" package should match that level of evidence, that is, a comfort service rather than a required step.

The Fitzpatrick I–III population in the carboxytherapy trial deserves a note for Vietnamese readers: most of us are types III–IV, a group with a distinctly higher tendency toward post-inflammatory hyperpigmentation. Results in fair skin do not transfer automatically to ours.

6. LED — the most studied, and for that reason the most modest

A red-light session with eye shielding — the most studied group of post-laser technology, yet the one with the most inconsistent results

LED therapy (photobiomodulation) uses red and near-infrared light at low energy, without meaningful heating, to act on cellular respiration and modulate the inflammatory response. It has more clinical trials behind it than the other three groups — which is exactly why the picture is more honest.

The most cited study is a split-face trial in 20 patients (Alster and Wanitphakdeedecha, Dermatologic Surgery, 2009), applying 590-nm LED immediately after 1550-nm non-ablative fractional resurfacing. The LED-treated side was less erythematous at 24 hours; in a small subgroup receiving the highest energy densities the difference persisted to 48 hours — but by 96 hours no difference between the two sides was discernible in any patient.

A more recent intraindividual randomised controlled trial is blunter still: 25 volunteers received ablative fractional laser to both inner biceps, with one side treated by an LED device emitting three wavelengths (465 nm, 640 nm and 880 nm) for 30 minutes, three times weekly for four weeks. Three blinded evaluators picked the treated side as faster-healing in 14/25, 14/25 and 17/25 cases respectively — and the authors concluded that the differences in healing speed, pain, discomfort and itch were not statistically significant. Erythema resolved around day 27 on both sides.

In short: LED has a plausible biological basis, is safe, and may shorten the sensation of redness over the first day or two. It does not reliably shorten overall recovery, and it does not substitute for sun protection.

7. Better evidence than all four: what you put on the skin

An Eternal Beauty Center technician applying a recovery product after a treatment — the step with the clearest evidence during recovery

This is the counterintuitive part. While device trials return mixed results, trials of topical products applied to freshly lasered skin return clearer results, with larger samples — and, importantly, in skin types close to ours.

Multi-molecular-weight hyaluronic acid dressing. A randomised controlled trial in 60 patients with Fitzpatrick types II–IV at a dermatology hospital in Shanghai, after fractional CO2 laser: the HA dressing group had lower transepidermal water loss at day 14 (16.69 versus 19.79; p = 0.009), lower erythema index at days 3, 7 and 14, and shorter pain duration (0.20 versus 0.53 days; p = 0.014). Notably there was no difference in melanin index — meaning it helps skin settle and close faster, not that it prevents pigmentation. The study was funded by a dermatological company, with follow-up of only 14 days.

Antioxidant serum with vitamin C, vitamin E and ferulic acid. An investigator-blinded, split-face trial in 64 Chinese patients, all Fitzpatrick type IV, treated for atrophic acne scars with fractional CO2 laser, against normal saline on the contralateral side: complete scab detachment at day 7 was 60.9% versus 34.4% (p = 0.0026), with lower erythema and melanin indices on the serum side (p < 0.0001). This study was funded by a cosmetics group.

The second result deserves a caveat, since it appears to contradict the familiar advice to avoid vitamin C after laser. The reasonable reconciliation: that advice exists to prevent irritation from high-concentration, low-pH ascorbic acid formulations common in ordinary skincare, whereas the trial used one specific formulation, on a defined protocol, under supervision. This is precisely the kind of finding that must not be generalised into "vitamin C after laser is good". If your treating physician has not prescribed it, do not add it yourself.

Beyond that, expert consensus on periprocedural care holds to the fundamentals: occlusive moisturisers containing petrolatum or dimethicone for moderate to severe disruption, broad-spectrum SPF 50+ as soon as the skin tolerates it, and staged reintroduction of prescription actives by severity — roughly 4–12 days for mild disruption, 2–3 weeks for moderate, and 24 days or more for severe, at the practitioner's judgement. Why sun protection is the decisive variable rather than a soft suggestion is covered in sun protection done properly.

8. Four questions to ask before paying for a high-tech recovery package

1. At what stage is this mode used, and for what? Pain control during the pass, soothing afterwards, or presented as "improving treatment results"? Only the first two are grounded.

2. What is in the solution being delivered, and is it sterile? On freshly ablated skin this is a safety question, not curiosity.

3. If I skip this part, does my result change? An honest answer is "the result is the same, you will just be more comfortable". If you are told the result would be worse, ask which evidence supports that.

4. Am I in the group prone to post-inflammatory hyperpigmentation, and what does that change about my aftercare? For most Vietnamese patients this question matters more than the other three.

9. How this is approached at Eternal Beauty Center

A dermatologist discussing an aftercare plan with a client at Eternal Beauty Center, Gò Vấp

At Eternal Beauty Center, post-procedure support is kept in its proper place: a layer of care that makes recovery more comfortable and more stable, not a service that promises a different treatment outcome.

The working principles:

  • Assess the skin first, choose support second. A skin analysis and consultation establishes skin type, pigmentation tendency and barrier status — the three factors that shape aftercare, including the decision to postpone a session.

  • Prioritise what has evidence. Barrier-repair moisturising, appropriate occlusion, sun protection and keeping crusts intact come before any device mode.

  • Be honest about what is uncertain. Where the data are thin, clients are told plainly that the mode is for comfort, not for outcome.

  • For patients on the multimodal E-Scar acne scar protocol, aftercare is planned alongside the intervention rather than considered once the session is over. When the skin only needs a gentle session to settle, Aquapeel is usually a better fit than adding another strong intervention.

Frequently asked questions

Generally no. Skin heals on its own biological schedule. What genuinely slows it down is picking crusts, sun exposure, resuming actives too early and letting the skin dry out. Support technologies act on discomfort more than on healing speed.

Usually yes, and it is commonly advised, but ask your treating physician about the specifics. The general rules: cool indirectly through clean gauze, in short intervals, never ice directly on the skin, and stop immediately if the area goes numb. Excessive or prolonged cold can cause a cold burn.

Current evidence does not support that claim. Trials of LED after laser have focused on erythema and healing speed, and results have been mixed even on those endpoints. The best-grounded ways to reduce pigmentation risk remain early inflammation control, strict sun protection, and leaving crusts alone.

It depends on the depth of the intervention and must be decided by your treating physician. The principle is that only non-frictional, non-ablative, active-free procedures are considered while the skin is still open; routine treatments wait until it has stabilised.

The number of modes says nothing about treatment quality. What decides the outcome is correct indication, settings matched to the skin, and an aftercare plan — the same platform in two different pairs of hands still produces two different results.

Yes, if pain is increasing rather than settling, if there is cloudy discharge, odour, fever, redness spreading beyond the treated area, or clustered blisters. These warrant early assessment rather than waiting it out.

Quick summary

  • After ablative fractional laser the barrier is temporarily open — everything applied goes deeper, so the ingredient matters more than the technology delivering it.

  • Cooling has the clearest rationale for pain relief but is not automatically harmless: a study in 23 Thai women found higher pigmentation risk on the cooled side during Q-switched laser treatment of Hori's nevus — not transferable to CO2 laser, but enough to stop treating cooling as a default.

  • Ultrasound or iontophoretic delivery rests on data from intact skin; on lasered skin the laser has already opened the route.

  • Oxygen and misting have the thinnest evidence — small studies, frequently uncontrolled, mostly manufacturer-funded.

  • LED is safe and may reduce redness over the first day or two, but a recent controlled trial found no statistically significant difference in healing speed.

  • The clearest evidence sits with topical products: an HA dressing and an antioxidant serum both outperformed controls in type II–IV skin, the population closest to Vietnamese patients.

Book a skin analysis and recovery plan

If you are preparing for laser, or have had it elsewhere and are unsure whether you are caring for your skin correctly, a skin analysis and consultation will answer more specifically than any article — because aftercare depends on your own skin type and pigmentation tendency.

Eternal Beauty Center

204 Đường Số 1, An Hội Đông Ward, Ho Chi Minh City (formerly Gò Vấp District)

Hotline / Zalo: 0334 713 610

View on the map

This article is health education and does not replace an in-person consultation. Indications, settings and aftercare plans must be decided by your treating physician for your individual case.

References

1. Manuskiatti W, Eimpunth S, Wanitphakdeedecha R. Effect of cold air cooling on the incidence of postinflammatory hyperpigmentation after Q-switched Nd:YAG laser treatment of acquired bilateral nevus of Ota-like macules. Arch Dermatol. 2007.

2. Alster TS, Wanitphakdeedecha R. Improvement of postfractional laser erythema with light-emitting diode photomodulation. Dermatol Surg. 2009. PMID 19397672.

3. The effect of combined red, blue, and near-infrared light-emitting diode (LED) photobiomodulation therapy on speed of wound healing after superficial ablative fractional resurfacing. 2024. PMC10965566.

4. Effect and Safety of Skincare Regimens Containing a Multi-Molecular Hyaluronic Acid Complex for Recovery After Ablative Fractional CO2 Laser: A Prospective, Randomized, Controlled Trial. 2025. PMC12210091.

5. Reparative Effects of a Topical Antioxidant Serum Containing Vitamin C, Vitamin E, and Ferulic Acid After Ablative Fractional CO2 Laser Treatment for Atrophic Acne Scars: A Randomized, Investigator-Blinded, Split-Face, Controlled Trial. PMC12793811.

6. Recommendations on Periprocedural Skincare for Energy-Based Dermatologic Procedures. Panel consensus, 2025. PMC12198435.

7. Efficacy of Carboxytherapy Mask in Post-Fractional Ablative Laser Recovery: A Randomized Pilot Trial. 2025. PMC12509481.

8. Periprocedural Use of Hypochlorous Acid Mist for Improving Healing and Cosmesis of the Face After Laser. 2025. PMC12365733.

9. Das A, Sarda A, De A. Cooling Devices in Laser Therapy. J Cutan Aesthet Surg. 2016.

10. Safety of Ablative Fractional Laser-Assisted Drug Delivery. J Am Acad Dermatol. 2024 (abstract 49921).

11. Marathe D, et al. Low-Frequency Sonophoresis: A Promising Strategy for Enhanced Transdermal Delivery. Adv Pharmacol Pharm Sci. 2024.

Not sure which treatment is right for you?

Book a free consultation with our specialist for a personalised skin analysis and treatment recommendation.

By registering, you agree to our Terms of Use .